Publicaciones en colaboración con investigadores/as de Universidad de Salamanca (19)

2024

  1. Cuidados continuos en oncología (III): infecciones en el paciente con cáncer, neutropenia febril

    Oncología clínica (Arán Ediciones), pp. 175-188

  2. Cáncer de cabeza y cuello

    Oncología clínica (Arán Ediciones), pp. 259-271

  3. Cáncer de pulmón

    Oncología clínica (Arán Ediciones), pp. 227-257

  4. Diagnóstico nosológico y de extensión. Factores pronósticos

    Oncología clínica (Arán Ediciones), pp. 59-71

  5. Melanoma maligno

    Oncología clínica (Arán Ediciones), pp. 381-394

  6. Tumores de origen desconocido

    Oncología clínica (Arán Ediciones), pp. 407-418

  7. Urgencias en oncología

    Oncología clínica (Arán Ediciones), pp. 129-145

2023

  1. Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality

    Precision Cancer Medicine

  2. Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data

    Cancers, Vol. 15, Núm. 17

  3. Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis

    Chinese Clinical Oncology, Vol. 12, Núm. 6

  4. Reply to «Considerations to the manuscript cancer and elderly: Two incompatible concepts for intensive care?»

    Revista Espanola de Geriatria y Gerontologia

2022

  1. Acquired haemophilia A secondary to metastatic prostate cancer

    Medicina Clinica

  2. Cancer and elderly: Two incompatible concepts for intensive care?

    Revista Espanola de Geriatria y Gerontologia

  3. Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88

  4. Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

    Biomedicines, Vol. 10, Núm. 2

2021

  1. Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications

    Biomolecules, Vol. 11, Núm. 2, pp. 1-16

  2. Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors

    Life, Vol. 11, Núm. 12

  3. Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies

    Journal of Clinical Medicine, Vol. 10, Núm. 9

2020

  1. Management of Febrile Neutropenia Associated with SARS-CoV-2 Infection in a Patient with Cancer

    JCO Oncology Practice